Related Experiment Video
Updated: Jul 16, 2026
09:17
Optimizing Extracellular Vesicle Delivery Using a Core-Sheath 3D-Bioprinted Scaffold for Chronic Wound Management
Published on: February 28, 2025
Tuning Hydrogel Mechanics and Microstructure to Maximize Extracellular Vesicle Production from Mesenchymal Stem Cells
Riddhesh B Doshi1,2, Bethany Yee1, Nicolas Warburton1
1Australian Centre for NanoMedicine, School of Chemistry, University of New South Wales (UNSW), Sydney, NSW 2052 Australia.
Cellular and Molecular Bioengineering
|July 15, 2026
Summary
Mesenchymal stem cell (MSC) derived extracellular vesicles (EVs) show therapeutic promise. Optimizing EV production using soft hydrogel microcarriers significantly increased yield and enhanced regenerative properties for biotechnology applications.
Area of Science:
- Biotechnology
- Regenerative Medicine
- Biomaterials
Background:
- Mesenchymal stem cells (MSCs) secrete extracellular vesicles (EVs) with therapeutic potential.
- EVs offer advantages in stability and delivery over other therapeutics.
- Scalable and reproducible EV production remains a significant challenge for therapeutic applications.
Purpose of the Study:
- To optimize extracellular vesicle (EV) production from mesenchymal stem cells (MSCs).
- To investigate the use of soft hydrogel microcarriers for enhanced EV yield and function.
- To evaluate the therapeutic potential of EVs produced via this novel method.
Main Methods:
- Gelatin methacryloyl (GelMA) hydrogels of varying concentrations were prepared.
- Two sources of MSCs (ADSCs and iMSCs) were cultured on hydrogels.
- EVs were isolated and characterized using electron microscopy, nanoparticle tracking, proteomics, and functional assays.
Main Results:
- MSC and EV production were optimized on 10 kPa hydrogels.
- Hydrogel microcarriers increased EV secretion by 18-fold compared to traditional monolayer cultures.
- EVs from microcarrier cultures exhibited enhanced wound healing and regenerative properties.
Conclusions:
- Soft hydrogel microcarriers represent an effective strategy for optimizing EV production from MSCs.
- This method offers a scalable approach for manufacturing therapeutic EVs.
- Optimized EV production holds significant promise for biotechnology and biomedical applications.
